Optimized human cell products for research and drug discovery

Member of the European Bank for induced Pluripotent Stem Cells EBiSC

Delivering human cell solutions for regenerative medicine

DefiniGEN provide a wide range of human cell products including liver, pancreas, and lung cells to the life science and drug discovery sectors using its proprietary OptiDIFF platform.

Def HEP Hepatocytes Alpha 1 Antitrypsin Deficiency

DefiniGEN provide a range of iPS-derived human liver, pancreatic and lung cells which are both healthy and disease modelled.

Read More

Def HEP Hepatocytes Glycogen Storage Disease 1A

DefiniGEN provide a range of iPS-derived human liver, pancreatic and lung cells which are both healthy and disease modelled.

Read More

Def HEP Hepatocytes

DefiniGEN provide a range of iPS-derived human liver, pancreatic and lung cells which are both healthy and disease modelled.

Read More

Def LUNG Distal Airway Human Lung Cells

DefiniGEN provide a range of iPS-derived human liver, pancreatic and lung cells which are both healthy and disease modelled.

Read More

Def PANC Beta Cell

DefiniGEN provide a range of iPS-derived human liver, pancreatic and lung cells which are both healthy and disease modelled.

Read More

Contract Services

DefiniGEN offers state of the art compound profiling services for a range of diseases including diabetes and cystic fibrosis.

Read More

Custom Cell Development

DefiniGEN harnesses the power of CRISPR genome editing, iPS technology, and directed differentiation to produce client-specified cell models using its OptiDIFF platform.

Read More